FDA: Suicide Risk For Users Of Pfizer’s Anti-Smoking Drug Chantix
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency warning echoes changed label; so far, 34 suicides and 420 cases of suicidal thoughts.
You may also be interested in...
Chantix Faces FDA Safety Gauntlet After Pfizer Settles Product Liability Suits
FDA advisory committees will discuss risk of serious neuropsychiatric adverse events with the smoking cessation drug at October meeting.
FDA Suicidality Reassessments Will Be Made At Division Level, Not Through Guidance
Decisions on whether to add drugs or classes of drugs to a list FDA has published of investigational products that need suicidality assessments will be made at the division level, the agency says.
FDA Suicidality Reassessments Will Be Made At Division Level, Not Through Guidance
Decisions on whether to add drugs or classes of drugs to a list FDA has published of investigational products that need suicidality assessments will be made at the division level, the agency says.